John D Buynak

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Multidrug Resistant

Molecular Docking

Cystic Fibrosis

Top Venues

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Nichole K Stewart, Marta Toth, Pojun Quan, Michael Beer, John D Buynak, Clyde A Smith, Sergei B Vakulenko
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase. ACS infectious diseases (2024)
Nichole K Stewart, Marta Toth, Pojun Quan, Michael Beer, John D Buynak, Clyde A Smith, Sergei B Vakulenko
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase. ACS infectious diseases (2024)
Nichole K Stewart, Marta Toth, Pojun Quan, Michael Beer, John D Buynak, Clyde A Smith, Sergei B Vakulenko
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase. ACS infectious diseases 10 (4) (2024)
Nichole K Stewart, Marta Toth, Pojun Quan, Michael Beer, John D Buynak, Clyde A Smith, Sergei B Vakulenko
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase. ACS infectious diseases 10 (4) (2024)
Nichole K Stewart, Marta Toth, Pojun Quan, Michael Beer, John D Buynak, Clyde A Smith, Sergei B Vakulenko
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase. ACS infectious diseases 10 (4) (2024)
Nichole K Stewart, Marta Toth, Pojun Quan, Michael Beer, John D Buynak, Clyde A Smith, Sergei B Vakulenko
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase. ACS infectious diseases 10 (4) (2024)
Nichole K Stewart, Marta Toth, Pojun Quan, Michael Beer, John D Buynak, Clyde A Smith, Sergei B Vakulenko
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase. ACS infectious diseases 10 (4) (2024)
Nichole K Stewart, Marta Toth, Pojun Quan, Michael Beer, John D Buynak, Clyde A Smith, Sergei B Vakulenko
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase. ACS infectious diseases 10 (4) (2024)
Clyde A Smith, Nichole K Stewart, Marta Toth, Pojun Quan, John D Buynak, Sergei B Vakulenko
The C5α-Methyl-Substituted Carbapenem NA-1-157 Exhibits Potent Activity against Klebsiella spp. Isolates Producing OXA-48-Type Carbapenemases. ACS infectious diseases 9 (5) (2023)
Clyde A Smith, Nichole K Stewart, Marta Toth, Pojun Quan, John D Buynak, Sergei B Vakulenko
The C5α-Methyl-Substituted Carbapenem NA-1-157 Exhibits Potent Activity against Klebsiella spp. Isolates Producing OXA-48-Type Carbapenemases. ACS infectious diseases (2023)
Clyde A Smith, Nichole K Stewart, Marta Toth, Pojun Quan, John D Buynak, Sergei B Vakulenko
The C5α-Methyl-Substituted Carbapenem NA-1-157 Exhibits Potent Activity against Klebsiella spp. Isolates Producing OXA-48-Type Carbapenemases. ACS infectious diseases 9 (5) (2023)
Clyde A Smith, Nichole K Stewart, Marta Toth, Pojun Quan, John D Buynak, Sergei B Vakulenko
The C5α-Methyl-Substituted Carbapenem NA-1-157 Exhibits Potent Activity against Klebsiella spp. Isolates Producing OXA-48-Type Carbapenemases. ACS infectious diseases 9 (5) (2023)
Rashmi Gupta, Noora M S A Al-Kharji, Maha A Alqurafi, Thu Q Nguyen, Weirui Chai, Pojun Quan, Riya Malhotra, Breven S Simcox, Phil Mortimer, Leighanne A Brammer Basta, Kyle H Rohde, John D Buynak
Atypically Modified Carbapenem Antibiotics Display Improved Antimycobacterial Activity in the Absence of β-Lactamase Inhibitors. ACS infectious diseases 7 (8) (2021)